Literature DB >> 9784247

Species differences in L-tryptophan-kynurenine pathway metabolism: quantification of anthranilic acid and its related enzymes.

S Fujigaki1, K Saito, M Takemura, H Fujii, H Wada, A Noma, M Seishima.   

Abstract

Anthranilic acid (AA) has attracted considerable attention as one of the L-tryptophan-kynurenine pathway metabolites in the central nervous system. In this study, a highly sensitive and accurate method for the quantification of AA has been developed using reversed-phase high-performance liquid chromatography with electrochemical detection. Serum and cerebrospinal fluid (CSF) AA concentrations in different animal species were measured. CSF AA concentrations in rabbits were 1.1 +/- 0.1 nmol/liter, which were 5. 7-33.0 times lower than those in other species studied. Serum AA concentrations, however, were slightly higher in rabbits than in other species. In contrast, the concentrations of L-kynurenine (L-KYN) in both serum and CSF were substantially higher in rabbits than in other species. Tissue kynurenine pathway enzymes, indoleamine 2,3-dioxygenase (IDO), tryptophan 2,3-dioxygenase, kynurenine 3-hydroxylase, and kynureninase were determined in rabbits, rats, gerbils, and mice. These enzymes varied among species, especially lung IDO activities in rabbits were 146-516 times higher than those found in other species, but rabbit liver kynurenine 3-hydroxylase activities were lower by one order of magnitude than those of the other species tested. Furthermore, brain kynurenine 3-hydroxylasae activities were 12.3-23.2 times higher in gerbils than those in the other species tested. In addition, AA concentrations in serum following intravenous administration of L-KYN (5 mg/kg) were also measured in rabbits. AA levels peaked sharply within 5 min after administration and decreased in a time-dependent manner. At 5 min after administration, CSF L-KYN and AA concentrations were also increased by 1.76- and 2.56-fold, respectively, compared with basal levels. Increased AA concentrations in CSF following L-KYN administration may reflect the entry of AA into the CSF after conversion to AA in systemic tissue and/or the local synthesis of AA from L-KYN in the CNS. Copyright 1998 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9784247     DOI: 10.1006/abbi.1998.0861

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  24 in total

1.  Model of tryptophan metabolism, readily scalable using tissue-specific gene expression data.

Authors:  Anne-Kristin Stavrum; Ines Heiland; Stefan Schuster; Pål Puntervoll; Mathias Ziegler
Journal:  J Biol Chem       Date:  2013-10-15       Impact factor: 5.157

2.  L-tryptophan-L-kynurenine pathway metabolism accelerated by Toxoplasma gondii infection is abolished in gamma interferon-gene-deficient mice: cross-regulation between inducible nitric oxide synthase and indoleamine-2,3-dioxygenase.

Authors:  Suwako Fujigaki; Kuniaki Saito; Masao Takemura; Naoya Maekawa; Yasuhiro Yamada; Hisayasu Wada; Mitsuru Seishima
Journal:  Infect Immun       Date:  2002-02       Impact factor: 3.441

3.  Kynurenine pathway metabolites in humans: disease and healthy States.

Authors:  Yiquan Chen; Gilles J Guillemin
Journal:  Int J Tryptophan Res       Date:  2009-01-08

Review 4.  Involvement of quinolinic acid in AIDS dementia complex.

Authors:  Gilles J Guillemin; Stephen J Kerr; Bruce J Brew
Journal:  Neurotox Res       Date:  2005       Impact factor: 3.911

Review 5.  The role of indoleamine 2,3-dioxygenase in allergic disorders.

Authors:  Seyed-Alireza Esmaeili; Jafar Hajavi
Journal:  Mol Biol Rep       Date:  2022-01-14       Impact factor: 2.316

6.  Effect of water-immersion restraint stress on tryptophan catabolism through the kynurenine pathway in rat tissues.

Authors:  Yoshiji Ohta; Hisako Kubo; Koji Yashiro; Koji Ohashi; Yuji Tsuzuki; Naoya Wada; Yasuko Yamamoto; Kuniaki Saito
Journal:  J Physiol Sci       Date:  2016-06-30       Impact factor: 2.781

7.  Mast cells' involvement in inflammation pathways linked to depression: evidence in mastocytosis.

Authors:  S Georgin-Lavialle; D S Moura; A Salvador; J-C Chauvet-Gelinier; J-M Launay; G Damaj; F Côté; E Soucié; M-O Chandesris; S Barète; C Grandpeix-Guyodo; C Bachmeyer; M-A Alyanakian; A Aouba; O Lortholary; P Dubreuil; J-R Teyssier; B Trojak; E Haffen; P Vandel; B Bonin; O Hermine; R Gaillard
Journal:  Mol Psychiatry       Date:  2016-01-26       Impact factor: 15.992

8.  Glia- and tissue-specific changes in the Kynurenine Pathway after treatment of mice with lipopolysaccharide and dexamethasone.

Authors:  Carlos R Dostal; Nicolaus S Gamsby; Marcus A Lawson; Robert H McCusker
Journal:  Brain Behav Immun       Date:  2017-12-11       Impact factor: 7.217

9.  Effects of indoleamine 2,3-dioxygenase inhibitor in non-Hodgkin lymphoma model mice.

Authors:  Nobuhiko Nakamura; Takeshi Hara; Masahito Shimizu; Ryoko Mabuchi; Junji Nagano; Tomohiko Ohno; Takahiro Kochi; Masaya Kubota; Yohei Shirakami; Naoe Goto; Hiroyasu Ito; Kuniaki Saito; Takuji Tanaka; Hisataka Moriwaki; Hisashi Tsurumi
Journal:  Int J Hematol       Date:  2015-08-05       Impact factor: 2.490

10.  Characterization of the kynurenine pathway and quinolinic Acid production in macaque macrophages.

Authors:  Chai K Lim; Margaret M C Yap; Stephen J Kent; Gabriel Gras; Boubekeur Samah; Jane C Batten; Robert De Rose; Benjamin Heng; Bruce J Brew; Gilles J Guillemin
Journal:  Int J Tryptophan Res       Date:  2013-05-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.